States/UTs to get over 4L Covid vaccine doses in next 3 days

More than four lakh (4,48,760) vaccine doses are in the pipeline and will be received by the States and the Union Territories (UTs) within the next 3 days.

Vaccination, coronavirus
Photo: Bloomberg
IANS New Delhi
2 min read Last Updated : Jun 13 2021 | 2:30 PM IST

More than four lakh (4,48,760) vaccine doses are in the pipeline and will be received by the States and the Union Territories (UTs) within the next 3 days.

Ministry of Health and Family Welfare (MoHFW) made the announcement through a statement and also clarified that more than 1.53 crore (1,53,79,233) Covid-19 vaccine doses are still available with the states and the UTs to be administered.

The Ministry further said that more than 26 crore (26,64,84,350) vaccine doses have been provided to states and the UTs so far, through government of India (free of cost channel) and through direct state procurement category.

Of this, the total consumption, including wastages is 25,12,66,637 doses, reveals the data available at 8 a.m. on Sunday.

As part of the nationwide vaccination drive, the Central government has been supporting the states and the UTs by providing them Covid vaccines free of cost.

In addition, the Central government has also been facilitating direct procurement of vaccines by the states and the UTs.

Vaccination is an integral pillar of the comprehensive strategy of the Central government for containment and management of the pandemic, along with Test, Track, Treat and Covid appropriate behaviour.

In this direction, the Central government implemented the Liberalized and Accelerated Phase-3 Strategy of Covid-19 vaccination on May 1 this year covering people aged above 18 years. India's vaccination drive began on January 16.

Under the strategy, in every month 50 per cent of the total Central Drugs Laboratory (CDL) cleared vaccine doses of any manufacturer would be procured by the Central government. It would continue to make these doses available to the state governments totally free of cost as was being done earlier.

--IANS

rak/skp/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Jun 13 2021 | 2:30 PM IST

Next Story